These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 15023108)

  • 1. Dantrolene--a review of its pharmacology, therapeutic use and new developments.
    Krause T; Gerbershagen MU; Fiege M; Weisshorn R; Wappler F
    Anaesthesia; 2004 Apr; 59(4):364-73. PubMed ID: 15023108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dantrolene. Pharmacological and therapeutic aspects].
    Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
    Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
    Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
    Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
    Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant hyperthermia].
    Zimprich F; Kress HG; Zeitlhofer J
    Wien Klin Wochenschr; 2003 Sep; 115(15-16):556-62. PubMed ID: 14531168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia].
    Schulte-Sasse U; Komar K; Eberlein HJ
    Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant hyperthermia].
    Bouhajja B; Haddad F; Ben Ammar MS
    Tunis Med; 2002 Jul; 80(7):395-401. PubMed ID: 12611349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle.
    Palnitkar SS; Mickelson JR; Louis CF; Parness J
    Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):847-52. PubMed ID: 9307036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia.
    Ali SZ; Taguchi A; Rosenberg H
    Best Pract Res Clin Anaesthesiol; 2003 Dec; 17(4):519-33. PubMed ID: 14661655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.
    López JR; Medina P; Alamo L
    Muscle Nerve; 1987 Jan; 10(1):77-9. PubMed ID: 3561441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
    Spiess-Kiefer C; Hippius H
    Fortschr Neurol Psychiatr; 1986 May; 54(5):158-70. PubMed ID: 2426164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]Azidodantrolene: synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum.
    Palnitkar SS; Bin B; Jimenez LS; Morimoto H; Williams PG; Paul-Pletzer K; Parness J
    J Med Chem; 1999 Jun; 42(11):1872-80. PubMed ID: 10354395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of a complicated case of neuroleptic malignant syndrome.
    Lappa A; Podestà M; Capelli O; Castagna A; Di Placido G; Alampi D; Semeraro F
    Intensive Care Med; 2002 Jul; 28(7):976-7. PubMed ID: 12122539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene.
    Cherednichenko G; Ward CW; Feng W; Cabrales E; Michaelson L; Samso M; López JR; Allen PD; Pessah IN
    Mol Pharmacol; 2008 Apr; 73(4):1203-12. PubMed ID: 18171728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.
    Nelson TE; Lin M; Zapata-Sudo G; Sudo RT
    Anesthesiology; 1996 Jun; 84(6):1368-79. PubMed ID: 8669678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dantrolene stabilizes domain interactions within the ryanodine receptor.
    Kobayashi S; Bannister ML; Gangopadhyay JP; Hamada T; Parness J; Ikemoto N
    J Biol Chem; 2005 Feb; 280(8):6580-7. PubMed ID: 15611117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome.
    Nisijima K; Noguti M; Ishiguro T
    Biol Psychiatry; 1997 Apr; 41(8):913-4. PubMed ID: 9099421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.